Denali Therapeutics Inc (DNLI)
24.49
+0.07
(+0.29%)
USD |
NASDAQ |
Nov 21, 14:14
Denali Therapeutics Price: 24.49 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 24.18 | 24.83 | 23.82 | 24.42 | 767094.0 |
Nov 19, 2024 | 24.00 | 24.37 | 23.53 | 24.34 | 1.012M |
Nov 18, 2024 | 25.07 | 25.35 | 24.06 | 24.18 | 1.157M |
Nov 15, 2024 | 28.38 | 28.62 | 25.00 | 25.05 | 1.103M |
Nov 14, 2024 | 29.63 | 29.80 | 28.29 | 28.45 | 831299.0 |
Nov 13, 2024 | 30.05 | 30.88 | 29.26 | 29.63 | 1.588M |
Nov 12, 2024 | 31.07 | 31.47 | 29.50 | 29.89 | 934442.0 |
Nov 11, 2024 | 32.00 | 33.33 | 31.56 | 31.58 | 797116.0 |
Nov 08, 2024 | 29.26 | 31.46 | 29.02 | 31.35 | 713529.0 |
Nov 07, 2024 | 29.25 | 31.40 | 29.02 | 29.60 | 885922.0 |
Nov 06, 2024 | 28.98 | 29.60 | 28.23 | 29.55 | 1.031M |
Nov 05, 2024 | 26.17 | 27.70 | 26.17 | 27.65 | 556620.0 |
Nov 04, 2024 | 26.91 | 27.63 | 26.76 | 27.21 | 607245.0 |
Nov 01, 2024 | 26.65 | 27.49 | 26.27 | 27.05 | 837711.0 |
Oct 31, 2024 | 26.64 | 26.74 | 25.55 | 25.96 | 557275.0 |
Oct 30, 2024 | 27.22 | 27.64 | 26.83 | 26.85 | 576418.0 |
Oct 29, 2024 | 27.64 | 27.74 | 26.98 | 27.47 | 1.756M |
Oct 28, 2024 | 26.50 | 27.80 | 26.23 | 27.78 | 810046.0 |
Oct 25, 2024 | 26.54 | 27.00 | 26.04 | 26.15 | 410066.0 |
Oct 24, 2024 | 26.31 | 26.60 | 26.01 | 26.44 | 512262.0 |
Oct 23, 2024 | 26.12 | 26.47 | 25.85 | 26.08 | 371159.0 |
Oct 22, 2024 | 26.28 | 26.74 | 25.94 | 26.29 | 391813.0 |
Oct 21, 2024 | 27.36 | 27.49 | 26.11 | 26.38 | 487744.0 |
Oct 18, 2024 | 27.51 | 28.00 | 27.43 | 27.59 | 514767.0 |
Oct 17, 2024 | 27.74 | 27.91 | 27.18 | 27.42 | 599516.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
14.20
Minimum
Mar 16 2020
93.56
Maximum
Dec 22 2020
33.90
Average
28.63
Median
Oct 04 2024
Price Benchmarks
AIM ImmunoTech Inc | 0.2105 |
Perspective Therapeutics Inc | 3.035 |
Protalix BioTherapeutics Inc | 1.63 |
Electromed Inc | 27.99 |
Armata Pharmaceuticals Inc | 2.13 |
Price Related Metrics
PS Ratio | 11.24 |
Price to Book Value | 2.673 |
Earnings Yield | -11.27% |
Market Cap | 3.525B |